Last updated: November 14, 2023
Sponsor: Westlake University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Diabetes Prevention
Diabetic Gastroparesis
Diabetic Vitreous Hemorrhage
Treatment
N/AClinical Study ID
NCT05312450
20211117ZJS001
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Comply with the diagnosis of diabetes in western medicine and the diagnostic criteriaof type 2 diabetes in the "Guiding Principles for Clinical Research of New ChineseMedicines"; volunteer to participate and sign the informed consent form.
Exclusion
Exclusion Criteria:
- Major special diseases, such as mental system diseases or other cognitive impairment,cancer and other malignant wasting diseases.
Study Design
Total Participants: 600
Study Start date:
March 10, 2022
Estimated Completion Date:
November 01, 2024
Study Description
Connect with a study center
Westlake University
Hangzhou, Zhejiang 310024
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.